COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 35 filers reported holding COCRYSTAL PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $156,000 | -29.1% | 536,296 | 0.0% | 0.00% | – |
Q2 2022 | $220,000 | -44.2% | 536,296 | -25.1% | 0.00% | – |
Q1 2022 | $394,000 | -15.1% | 716,006 | +0.3% | 0.00% | – |
Q4 2021 | $464,000 | -38.1% | 714,011 | +0.0% | 0.00% | – |
Q3 2021 | $750,000 | -16.0% | 714,006 | 0.0% | 0.00% | – |
Q2 2021 | $893,000 | -10.9% | 714,006 | -1.0% | 0.00% | – |
Q1 2021 | $1,002,000 | +3.3% | 721,006 | +1.1% | 0.00% | – |
Q4 2020 | $970,000 | +46.3% | 713,240 | 0.0% | 0.00% | – |
Q3 2020 | $663,000 | -39.0% | 713,240 | -0.2% | 0.00% | – |
Q2 2020 | $1,086,000 | +114.2% | 714,740 | 0.0% | 0.00% | – |
Q1 2020 | $507,000 | +43.6% | 714,740 | +0.3% | 0.00% | – |
Q4 2019 | $353,000 | +4942.9% | 712,740 | +20264.0% | 0.00% | – |
Q3 2019 | $7,000 | -12.5% | 3,500 | 0.0% | 0.00% | – |
Q2 2019 | $8,000 | -81.0% | 3,500 | -77.4% | 0.00% | – |
Q1 2019 | $42,000 | -41.7% | 15,500 | -22.5% | 0.00% | – |
Q4 2018 | $72,000 | +80.0% | 20,000 | +24.7% | 0.00% | – |
Q3 2018 | $40,000 | – | 16,033 | +48484.8% | 0.00% | – |
Q2 2018 | $0 | – | 33 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 33 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 6,110,657 | $7,638,000 | 1.08% |
Altium Capital Management LP | 776,000 | $970,000 | 0.22% |
Alyeska Investment Group, L.P. | 2,750,100 | $3,438,000 | 0.04% |
Virtu Financial LLC | 116,625 | $146,000 | 0.01% |
Parallel Advisors, LLC | 184,708 | $231,000 | 0.01% |
Renaissance Technologies | 2,593,933 | $3,242,000 | 0.00% |
CIM, LLC | 11,000 | $12,000 | 0.00% |
Western Wealth Management, LLC | 19,115 | $24,000 | 0.00% |
Mariner, LLC | 200,055 | $250,000 | 0.00% |
BRIGHTON JONES LLC | 36,000 | $45,000 | 0.00% |